InterMune

Developer of therapies in pulmonology and hepatology. The company's products are approved for the treatment of patients with severe, malignant osteopetrosis and chronic granulomatous disease. It has an advanced-stage development pipeline in the pulmonology area and a research and development-stage pipeline in the hepatology area.

New Enterprise Associates

🏥 Healthcare